Sunitinib

75 kDa bromodomain protein, AAG6, ACEE, ACES_HUMAN, ARACHE, Acetylcholinesterase, Aging associated gene 6, Aland island eye disease (Forsius Eriksson ocular albinism, ocular albinism type 2), Apoptosis related acetylcholinesterase, BP75, BRD7_HUMAN, BSK, Brain-specific kinase, Bromodomain containing 7, Bromodomain containing 9, Bromodomain containing protein 9, Bromodomain-containing protein 7, CAC1C_HUMAN, CAC1D_HUMAN, CAC1F_HUMAN, CAC1S_HUMAN, CACH 2, CACH1, CACH3, CACN 2, CACN1, CACN4, CACNA 1D, CACNAF, CACNAF1, CACNL1A1, CACNL1A2, CACNL1A3, CCHL1A1, CCHL1A2, CCHL1A3, CEK 7, CELTIX 1, COD 3, CORDX, CORDX 3, CSNB2A, CSNBX 2, CaV1.2, Cach1b, Calcium channel, Calcium channel L type alpha 1 polypeptide isoform 1 cardiac muscle, Calcium channel L type alpha 1 polypeptide isoform 2, Calcium channel cardic dihydropyridine sensitive alpha 1 subunit, Calcium channel neuroendocrine/brain type alpha 1 subunit, Calcium channel voltage dependent L type alpha 1, Calcium channel voltage dependent L type alpha 1C subunit, Calcium channel voltage dependent L type alpha 1D subunit, Calcium channel voltage dependent L type alpha 1F subunit, Calcium channel voltage dependent alpha 1F subunit, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal muscle, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal muscle, hypokalemic periodic paralysis, Calcium channel, skeletal muscle dihydropyridine sensitive , alpha 1 subunit, Calcium channel, voltage dependent, L type, alpha 1S subunit, Calcium channel, voltage-dependent, L type, alpha 1S subunit, b, Cav1.1, Cav1.3, Cav1.4, Cav1.4alpha1, DHPR alpha 1, DHPR alpha 1 subunit, DKFZp434D0711, DKFZp686L0539, Dihydropyridine receptor, Dihydropyridine sensitive L type calcium channel alpha 1 subunit, EHK-1, EK7, EPH homology kinase 1, EPH-like kinase 7, EPHA5_HUMAN, Eck like sequence 1, Els 1, Ephrin type-A receptor 5, FLJ13441, FLJ42439, HEK 7, HOKPP, HypoPP, JM 8, JMC 8, KIAA0213, KPCA_HUMAN, L type, LAVS3040, LQT8, M3K4_HUMAN, MAP three kinase 1, MAP/ERK kinase kinase 4, MAPK/ERK kinase kinase 4, MAPKKK4, MEK kinase 4, MEKK 4, MHS5, MTK1, Malignant hyperthermia susceptibility 5, Mitogen-activated protein kinase kinase kinase 4, N-ACHE, NAG4, OTTHUMP00000025825, PASNA, PIM2_HUMAN, PKC-A, PKC-alpha, PRKACA, PRKCA, PRO0412, PRO9856, Pim 2 oncogene, Pim-2h, Protein CELTIX-1, Protein Kinase C alpha, Protein kinase C alpha type, Proto Oncogene PIM2, Proto-oncogene Pim-2 (serine threonine kinase), ROB1, RP3-473J16.4, Receptor protein tyrosine kinase HEK 7, Rek 7, Rhabdomyosarcoma antigen MU RMS 40.8, SANDD, SSK2/SSK22 MAP kinase kinase kinase, yeast, homolog of, Sarcoma antigen NY SAR 29, Serine/threonine kinase PIM2, Serine/threonine-protein kinase Pim-2, TS, TTPP1, TYRO 4, Tyrosine protein kinase receptor EHK 1, UNQ3040, Voltage dependent L type calcium channel alpha 1C subunit, Voltage ependent L ype calcium channel subunit alpha F, Voltage gated L type calcium channel Cav1.2 alpha 1 subunit, splice variant 10*, Voltage gated calcium channel alpha 1 subunit, Voltage gated calcium channel alpha 1F subunit, Voltage gated calcium channel alpha subunit Cav1.2, Voltage gated calcium channel alpha subunit Cav1.3, Voltage gated calcium channel subunit alpha Cav1.4, Voltage-dependent L-type calcium channel subunit alpha-1C, Voltage-dependent L-type calcium channel subunit alpha-1D, Voltage-dependent L-type calcium channel subunit alpha-1S, Voltage-gated calcium channel subunit alpha Cav1.1, Voltage-gated calcium channel subunit alpha Cav1.2, Voltage-gated calcium channel subunit alpha Cav1.3, YT, YT blood group, aPKC, alpha-1 polypeptide, cardiac muscle, dJ473J16.1 (mitogen-activated protein kinase kinase kinase 4), fmd, isoform 1, isoform 2, isoform 3, predicted protein of HQ0412, sj

Biochemicals